However, tumor-bearing Pgrmc1 KO mice showed a significantly longer survival duration (p = 0.0065) compared with tumor-bearing WT mice, suggesting that Pgrmc1 is related to the aggravation of the disease course of breast cancer (Fig. 1c). Here, PGRMC1 is linked to breast carcinoma.